Sontag Advisory »

Galectin Therapeutics shares owned by Sontag Advisory

Quarter-by-quarter ownership of Galectin Therapeutics (GALT) shares owned by Sontag Advisory from 13F filings

Historical chart of Sontag Advisory investment in Galectin Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Galectin Therapeutics held by Sontag Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galectin Therapeutics by Sontag Advisory

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 398k 2.75
2024-06-30 $900k 398k 2.26
2024-03-31 $952k 398k 2.39
2023-12-31 $305k 184k 1.66
2023-09-30 $353k 184k 1.92
2023-06-30 $265k 184k 1.44
2023-03-31 $386k 184k 2.10
2022-09-30 $28k 17k 1.61
2022-06-30 $23k 17k 1.33
2022-03-31 $28k 17k 1.61
2021-12-31 $29k 14k 2.09
2021-09-30 $54k 14k 3.90
2021-06-30 $44k 14k 3.18
2021-03-31 $30k 14k 2.17
2020-12-31 $31k 14k 2.24
2020-09-30 $37k 14k 2.67
2020-06-30 $42k 14k 3.03
2020-03-31 $27k 14k 1.95
2019-12-31 $40k 14k 2.89
2019-09-30 $51k 14k 3.68